Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Accumulated Depreciation & Amortization (2017 - 2020)

Historic Accumulated Depreciation & Amortization for Cogent Biosciences (COGT) over the last 4 years, with Q4 2020 value amounting to $412000.0.

  • Cogent Biosciences' Accumulated Depreciation & Amortization fell 9110.34% to $412000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $412000.0, marking a year-over-year decrease of 9110.34%. This contributed to the annual value of $412000.0 for FY2020, which is 9110.34% down from last year.
  • Latest data reveals that Cogent Biosciences reported Accumulated Depreciation & Amortization of $412000.0 as of Q4 2020, which was down 9110.34% from $4.6 million recorded in Q4 2019.
  • Over the past 5 years, Cogent Biosciences' Accumulated Depreciation & Amortization peaked at $4.6 million during Q4 2019, and registered a low of $412000.0 during Q4 2020.
  • For the 4-year period, Cogent Biosciences' Accumulated Depreciation & Amortization averaged around $2.7 million, with its median value being $2.8 million (2017).
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 6036.7% in 2018, then crashed by 9110.34% in 2020.
  • Cogent Biosciences' Accumulated Depreciation & Amortization (Quarter) stood at $2.2 million in 2017, then surged by 60.37% to $3.5 million in 2018, then surged by 32.47% to $4.6 million in 2019, then plummeted by 91.1% to $412000.0 in 2020.
  • Its Accumulated Depreciation & Amortization stands at $412000.0 for Q4 2020, versus $4.6 million for Q4 2019 and $3.5 million for Q4 2018.